Works Cited

1. World Health Organization. Milestones in Health Promotion: Statements from Global Conferences. Available at http://www.who.int/healthpromotion/Milestones_Health_Promotion_05022010.pdf. Last accessed July 10, 2018.

2. Young LE. Transforming health promotion practice: moving toward holistic care. In: Young LE, Hayes V (eds). Transforming Health Promotion Practice: Concepts, Issues and Applications. Philadelphia, PA: F.A. Davis Company; 2002.

3. West LA, Cole S, Goodkind D, He W. 65+ in the United States: 2010. Available at https://www.census.gov/content/dam/Census/library/publications/2014/demo/p23-212.pdf. Last accessed July 10, 2018.

4. United States Census Bureau. Facts for Features: Older Americans Month: May 2017. Available at https://www.census.gov/newsroom/facts-for-features/2017/cb17-ff08.html. Last accessed July 10, 2018.

5. Ortman JM, Velkoff VA, Hogan H. An Aging Nation: The Older Population in the United States. Available at https://www.census.gov/prod/2014pubs/p25-1140.pdf. Last accessed July 10, 2018.

6. Population Reference Bureau. Fact Sheet: Aging in the United States. Available at https://www.prb.org/aging-unitedstates-fact-sheet. Last accessed July 10, 2018.

7. Administration for Community Living. Minority Aging. Available at https://www.acl.gov/aging-and-disability-in-america/data-and-research/minority-aging. Last accessed July 10, 2018.

8. National Cancer Institute. Fact Sheet: Breast Cancer Risk in American Women. Available at https://www.cancer.gov/types/breast/risk-fact-sheet. Last accessed July 10, 2018.

9. American Cancer Society. Breast Cancer Facts and Figures 2017–2018. Available at https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/breast-cancer-facts-and-figures/breast-cancer-facts-and-figures-2017-2018.pdf. Last accessed July 10, 2018.

10. National Institutes of Health Office of Research on Women's Health. Moving into the Future with New Dimensions and Strategies for Women's Health Research: A Vision for 2020 for Women's Health Research. Available at https://orwh.od.nih.gov/sites/orwh/files/docs/ORWH_StrategicPlan2020_Vol1.pdf. Last accessed July 10, 2018.

11. U.S. Department of Health and Human Services. Healthy People 2020. Available at https://www.healthypeople.gov/2020/topics-objectives. Last accessed July 10, 2018.

12. MacDonald MA. Health promotion: historical, philosophical, and theoretical perspectives. In: Young LE, Hayes VE (eds). Transforming Health Promotion Practice: Concepts Issues and Applications. Philadelphia, PA: F.A. Davis Company; 2002: 22-45.

13. U.S. Department of Health and Human Services. Pap Test. Available at https://www.womenshealth.gov/a-z-topics/pap-test. Last accessed July 10, 2018.

14. Centers for Disease Control and Prevention. Making Sense of Your Pap and HPV Test Results. Available at https://www.cdc.gov/std/hpv/pap. Last accessed July 10, 2018.

15. Centers for Disease Control and Prevention. Incidence, Prevalence, and Cost of Sexually Transmitted Infections in the United States. Available at https://www.cdc.gov/std/stats/sti-estimates-fact-sheet-feb-2013.pdf. Last accessed July 10, 2018.

16. Workowski KA, Bolan GA. Sexually transmitted diseases treatment guidelines, 2015. MMWR. 2015;64(RR03):1-137.

17. Centers for Disease Control and Prevention. Sexually Transmitted Diseases (STDs). Available at https://www.cdc.gov/std. Last accessed July 10, 2018.

18. Youngkin EQ, Davis MS, Schadewald D, Juve C. Women's Health: A Primary Care Clinical Guide. 4th ed. Upper Saddle River, NJ: Prentice Hall; 2012.

19. Mitsui M, Tsukahara Y. STD and mother to child transmission. Nihon Rinsho. 2009;67(1):177-184.

20. Tjaden P, Thoennes N. Extent, Nature, and Consequences of Rape Victimization: Findings from the National Violence Against Women Survey. Available at https://www.ncjrs.gov/pdffiles1/nij/210346.pdf. Last accessed July 10, 2018.

21. Bernard HU, Burk RD, Chen Z, van Doorslaer K, zur Hausen H, de Villiers EM. Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments. Virology. 2010;401(1):70-79.

22. Berman NR. Human papillomavirus and cervical cancer screening: recent advances improve the clinical picture. Adv Nurse Pract. 2002;10(10):26-35.

23. American Cancer Society. FDA Approves Gardasil 9 HPV Vaccine. Available at https://www.cancer.org/latest-news/fda-approves-gardasil-9-hpv-vaccine.html. Last accessed July 9, 2018.

24. National Cancer Institute. Human Papillomavirus (HPV) Vaccines. Available at https://www.cancer.gov/about-cancer/causes-prevention/risk/infectious-agents/hpv-vaccine-fact-sheet. Last accessed July 10, 2018.

25. Meites E, Kempe A, Markowitz LE. Use of a 2-dose schedule for human papillomavirus vaccination—updated recommendations of the Advisory Committee on Immunization Practices. MMWR. 2016;65(49):1405-1408.

26. Centers for Disease Control and Prevention. Genital Herpes—CDC Fact Sheet. Available at https://www.cdc.gov/std/Herpes/STDFact-Herpes.htm. Last accessed July 10, 2018.

27. Chan PD. Obstetrics and Gynecology, 2011 Edition. Laguna Hills, CA: Current Clinical Strategies; 2011.

28. Corey L, Wald A, Patel R, et al. Once-daily valacyclovir to reduce the risk of transmission of genital herpes. N Engl J Med. 2004;350(1):11-20.

29. LexiComp Online. Available at http://online.lexi.com. Last accessed July 10, 2018.

30. Centers for Disease Control and Prevention. Trichomoniasis Statistics. Available at https://www.cdc.gov/std/trichomonas/stats.htm. Last accessed July 10, 2018.

31. Centers for Disease Control and Prevention. Trichomoniasis—CDC Fact Sheet. Available at https://www.cdc.gov/std/trichomonas/stdfact-trichomoniasis.htm. Last accessed July 10, 2018.

32. Centers for Disease Control and Prevention. 2016 Sexually Transmitted Diseases Surveillance. Available at https://www.cdc.gov/std/stats16/default.htm. Last accessed July 10, 2018.

33. Centers for Disease Control and Prevention. Syphilis—CDC Fact Sheet. Available at https://www.cdc.gov/std/syphilis/STDFact-Syphilis.htm. Last accessed July 10, 2018.

34. Cottrell BH. Vaginal douching. J Obstet Gynecol Neonatal Nurs. 2003;32(1):12-18.

35. Cottrell BH. An updated review of the evidence to discourage douching. MCN Am J Matern Child Nurs. 2010;35(2):102-107.

36. Taber's Online. Available at http://www.tabers.com/tabersonline/ub. Last accessed July 10, 2018.

37. Centers for Disease Control and Prevention. Bacterial Vaginosis—CDC Fact Sheet. Available at https://www.cdc.gov/std/BV/STDFact-Bacterial-Vaginosis.htm. Last accessed July 10, 2018.

38. Quan M. Vaginitis: diagnosis and management. Postgrad Med. 2010;122(6):117-127.

39. Mashburn J. Etiology, diagnosis, and management of vaginitis. J Midwifery Womens Health. 2006;51(6):423-430.

40. MedlinePlus. Pap Test. Available at https://medlineplus.gov/ency/article/003911.htm. Last accessed July 10, 2018.

41. Saslow D, Solomon D, Lawson HW, et al. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer.Am J Clin Pathol. 2012;137(4):516-542.

42. American Cancer Society. About Cervical Cancer. Available at https://www.cancer.org/content/dam/CRC/PDF/Public/8599.00.pdf. Last accessed July 10, 2018.

43. American Cancer Society. Survival Rates for Cervical Cancer, by Stage. Available at https://www.cancer.org/cancer/cervical-cancer/detection-diagnosis-staging/survival.html. Last accessed July 10, 2018.

44. Centers for Disease Control and Prevention. National Center for Health Statistics. Pap Tests. Health, United States, 2016, Table 71. Available at https://www.cdc.gov/nchs/fastats/pap-tests.htm. Last accessed July 10, 2018.

45. Wong QC, Collins R, Kalkstein K, Roth A, Gintautas J. Cervical cancer screening among elderly urban women in a primary care setting. Proc West Pharmacol Soc. 2005;48:154-156.

46. Spence AR, Goggin P, Franco EL. Process of care failures in invasive cervical cancer: systematic review and meta-analysis. Prev Med. 2007;45(2-3):93-106.

47. Freeman H, Wingrove B. Excess Cervical Cancer Mortality: A Marker for Low Access to Health Care in Poor Communities. Rockville, MD: National Cancer Institute; 2005.

48. Centers for Disease Control and Prevention. National Breast and Cervical Cancer Early Detection Program (NBCCEDP). Available at https://www.cdc.gov/cancer/nbccedp. Last accessed July 10, 2018.

49. Mayo Clinic. Cervical Cancer. Available at https://www.mayoclinic.org/diseases-conditions/cervical-cancer/symptoms-causes/syc-20352501. Last accessed July 10, 2018.

50. Frank JE. The colposcopic examination. J Midwifery Womens Health. 2008;53(5):447-452.

51. Haghighi F, Ghanbarzadeh N, Ataee M, Sharifzadeh G, Mojarrad JS, Najafi-Semnani F. A comparison of liquid-based cytology with convention Papanicolaou smears in cervical dysplasia diagnosis. Adv Biomed Res. 2016;5:162.

52. Seibers AG, Klinkhamer PJ, Grefte JM, et al. Comparison of liquid-based cytology with conventional cytology for detection of cervical cancer precursors: a randomized controlled trial. JAMA. 2009;302(16):1757-1764.

53. Department of Health and Human Services. P080015:Cervista HPV 16/18. Available at https://www.accessdata.fda.gov/cdrh_docs/pdf8/P080015A.pdf. Last accessed July 10, 2018.

54. Massad LS, Einstein MH, Huh WK, et al for the 2012 ASCCP Consensus Guidelines Conference. 2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors. J Lower Genital Tract Dis. 2013;17(5):S1-S27.

55. U.S. Food and Drug Administration. Nucleic Acid Based Tests. Available at https://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/InVitroDiagnostics/ucm330711.htm. Last accessed July 10, 2018.

56. U.S. Preventive Services Task Force. Final Recommendation Statement, Cervical Cancer: Screening. Available at https://www.uspreventiveservicestaskforce.org/Page/Document/UpdateSummaryFinal/cervical-cancer-screening. Last accessed October 11, 2018.

57. Centers for Disease Control and Prevention. Human Papillomavirus (HPV) Vaccine Safety. Available at https://www.cdc.gov/vaccinesafety/vaccines/hpv-vaccine.html. Last accessed July 10, 2018.

58. U.S. Food and Drug Administration. Vaccines, Blood and Biologics: Gardasil. Available at https://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM094042. Last accessed July 10, 2018.

59. U.S. Food and Drug Administration. Vaccines, Blood and Biologics: Cervarix. Available at https://www.fda.gov/biologicsbloodvaccines/vaccines/approvedproducts/ucm186957.htm. Last accessed July 10, 2018.

60. Apgar BS, Zoschnick L, Wright TC Jr. The 2001 Bethesda System terminology. Am Fam Physician. 2003;68(10):1992-1999.

61. Solomon D, Davey D, Kurman R, et al. The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA. 2002;287(16):2114-2119.

62. American Cancer Society. What Are the Risk Factors for Cervical Cancer? Available at https://www.cancer.org/cancer/cervical-cancer/causes-risks-prevention/risk-factors.html. Last accessed July 10, 2018.

63. Kinsey Institute. FAQs and Sex Information. Available at https://kinseyinstitute.org/research/faq.php. Last accessed July 10, 2018.

64. American Cancer Society. Treating Cervical Cancer. Available at https://www.cancer.org/cancer/cervical-cancer/treating.html. Last accessed July 10, 2018.

65. National Cancer Institute. Cervical Cancer Treatment (PDQ). Available at https://www.cancer.gov/types/cervical/patient/cervical-treatment-pdq#section/all. Last accessed July 10, 2018.

66. Carlson KJ, Eisenstat SA, Frigoletto FJ Jr, Schiff I (eds). Primary Care of Women. 2nd ed. St. Louis, MO: Mosby; 2002.

67. American Cancer Society. Endometrial Cancer. Available at https://www.cancer.org/cancer/endometrial-cancer.html. Last accessed July 10, 2018.

68. Allen KM, Phillips JM. Women's Health Across the Lifespan: A Comprehensive Perspective. Philadelphia, PA: Lippincott Williams & Wilkins; 1997.

69. Banno K, Susumu N, Yanokura M, et al. Association of HNPCC and endometrial cancers. Int J Clin Oncol. 2004;9(4):262-269.

70. American Cancer Society. Ovarian Cancer. Available at https://www.cancer.org/cancer/ovarian-cancer.html. Last accessed July 10, 2018.

71. American Cancer Society. Chemotherapy for Ovarian Cancer. Available at https://www.cancer.org/cancer/ovarian-cancer/treating/chemotherapy.html. Last accessed July 10, 2018.

72. American Cancer Society. Can Ovarian Cancer Be Prevented? Available at https://www.cancer.org/cancer/ovarian-cancer/causes-risks-prevention/prevention.html. Last accessed July 2, 2018.

73. Ekwall E, Ternestedt BM, Sorbe B. Important aspects of health care for women with gynecological cancer. Oncol Nurs Forum. 2003;30(2):313-319.

74. Anderson SE, Must A. Interpreting the continued decline in the average age at menarche: results from two nationally representative surveys of U.S. girls studied 10 years apart. J Pediatr. 2005;147(6):753-760.

75. Pritham UA. Managing PMS and PMDD. Exploring new treatment options. Nurs Womens Health. 2002;6(5):430-437.

76. Davis AR, Westhoff CL. Primary dysmenorrhea in adolescent girls and treatment with oral contraceptives. J Pediatr Adolesc Gynecol. 2001;14(1):3-8.

77. Mayo Clinic. Premenstrual Syndrome (PMS). Available at https://www.mayoclinic.org/diseases-conditions/premenstrual-syndrome/symptoms-causes/syc-20376780. Last accessed July 10, 2018.

78. Mayo Clinic. Menopause. Available at https://www.mayoclinic.org/diseases-conditions/menopause/symptoms-causes/syc-20353397. Last accessed July 10, 2018.

79. George SA. The menopause experience: a woman's perspective. J Obstet Gynecol Neonatal Nurs. 2006;31(1):77-85.

80. Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA. 2002;288(3):321-33.

81. Women's Health Initiative. Available at https://www.nhlbi.nih.gov/science/womens-health-initiative-whi. Last accessed July 10, 2018.

82. National Institutes of Health. Clinical Alert: NIH Asks Participants in Women's Health Initiative Estrogen-Alone Study to Stop Study Pills, Begin Follow-Up Phase. Available at https://www.nlm.nih.gov/databases/alerts/estrogen_alone.html. Last accessed July 10, 2018.

83. Shumaker SA, Legault C, Kuller L, et al. Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative memory study. JAMA. 2004;291(24):2947-2958.

84. Bruckner MC, Youngkin EQ. What's a woman to do? Exploring HRT questions raised by the women's health initiative. Nurs Womens Health. 2002;6(5):408-417.

85. Agency for Healthcare Research and Quality. Menopausal Symptoms: Comparative Effectiveness of Therapies. Available at https://effectivehealthcare.ahrq.gov/topics/menopause/research. Last accessed July 10, 2018.

86. National Breast Cancer Foundation. Breast Self-Exam (BSE). Available at http://www.nationalbreastcancer.org/breast-self-exam. Last accessed July 10, 2018.

87. Moyer VA, U.S. Preventive Services Task Force. Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2014;160(4):271-281.

88. National Cancer Institute. Breast Cancer Prevention (PDQ): Overview. Available at https://www.cancer.gov/types/breast/hp/breast-prevention-pdq#section/all. Last accessed July 10, 2018.

89. American Cancer Society. Understanding a Breast Cancer Diagnosis. Available at https://www.cancer.org/cancer/breast-cancer/understanding-a-breast-cancer-diagnosis.html. Last accessed July 10, 2018.

90. National Cancer Institute. Breast Cancer Screening (PDQ). Available at https://www.cancer.gov/types/breast/hp/breast-screening-pdq#section/all. Last accessed July 10, 2018.

91. Oeffinger KC, Fontham ETH, Etzioni R, et al. Breast cancer screening for women at average risk. 2015 guideline update from the American Cancer Society. JAMA. 2015;314(15):1599-1614.

92. The American College of Obstetricians and Gynecologists. Practice bulletin no. 179: breast cancer risk assessment and screening in average-risk women. Obstet Gynecol. 2017;179(130):e1-e16.

93. U.S. Preventive Services Task Force. Breast Cancer: Screening. Available at https://www.uspreventiveservicestaskforce.org/Page/Document/UpdateSummaryFinal/breast-cancer-screening1. Last accessed July 10, 2018.

94. National Cancer Institute. Breast Changes and Conditions. Available at https://www.cancer.gov/types/breast/breast-changes. Last accessed July 10, 2018.

95. Saslow D, Boetes C, Burke W, et al. American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin. 2007;57(2):75-89.

96. American Cancer Society. Press Release: American Cancer Society Responds to Changes to USPSTF Mammography Guidelines. Available at http://pressroom.cancer.org/releases?item=201. Last accessed July 10, 2018.

97. Breastcancer.org. Treatment and Side Effects. Available at https://www.breastcancer.org/treatment. Last accessed July 10, 2018.

98. American Cancer Society. Treating Breast Cancer. Available at https://www.cancer.org/cancer/breast-cancer/treatment.html. Last accessed July 10, 2018.

99. National Cancer Institute. Breast Cancer Treatment (PDQ). Available at https://www.cancer.gov/types/breast/hp/breast-treatment-pdq. Last accessed July 10, 2018.

100. Gonzalez-Angulo AM, Buzdar AU, Hortobagyi GN. Primary systemic therapy for operable breast cancer: present role and perspectives. In: Bonodonna G, Hortobagyi GN, Valagussa P (eds). Textbook of Breast Cancer: A Clinical Guide to Therapy. 3rd ed. London: Taylor and Francis Group; 2006.

101. Perez EA. Conventional adjuvant chemotherapy: where are we 30 years later? In: Bonodonna G, Hortobagyi GN, Valagussa P (eds). Textbook of Breast Cancer: A Clinical Guide to Therapy. 3rd ed. London: Taylor and Francis Group; 2006.

102. Breastcancer.org. What is Hormonal Therapy? Available at https://www.breastcancer.org/treatment/hormonal/what_is. Last accessed July 10, 2018.

103. Visvanathan K, Chlebowski RT, Hurley P, et al. American Society of Clinical Oncology clinical practice guideline update on the use of pharmacologic interventions including tamoxifen, raloxifene, and aromatase inhibition for breast cancer risk reduction.J Clin Oncol. 2009;27(19):3235-3258.

104. Singer CF, Kostler WJ, Hudelist G. Predicting the efficacy of trastuzumab-based therapy in breast cancer: current standards and future strategies. Biochim Biophys Acta. 2008;1786(2):105-113.

105. National Collaborating Centre for Cancer. Early and Locally Advanced Breast Cancer: Diagnosis and Treatment. London: National Institute for Health and Clinical Excellence; 2009.

106. National Cancer Institute. Trastuzumab. Available at https://www.cancer.gov/about-cancer/treatment/drugs/trastuzumab. Last accessed July 10, 2018.

107. Gonzalez-Angulo AM, Hortobagyi GN, Esteva FJ. Adjuvant therapy with trastuzumab for HER-2/neu-positive breast cancer. Oncologist. 2006;11(8):857-867.

108. Petrelli F, Coinu A, Borgonovo K, et al. The value of platinum agents as neoadjuvant chemotherapy in triple-negative breast cancers: a systematic review and meta-analysis. Breast Cancer Res Treat. 2014;144(2):223-232.

109. Li Z, Qiu Y, Lu W, Jiang Y, Wang J. Immunotherapeutic interventions of triple negative breast cancer. J Transl Med. 2018;16(1):147.

110. Jia H, Truica CI, Wang B, et al. Immunotherapy for triple-negative breast cancer: existing challenges and exciting prospects.Drug Resist Updat. 2017;32:1-15.

111. Kwa MJ, Adams S. Checkpoint inhibitors in triple-negative breast cancer (TNBC): where to go from here. Cancer. 2018;124(10):2086-2103.

112. National Cancer Institute. Hormone Therapy for Breast Cancer. Available at https://www.cancer.gov/types/breast/breast-hormone-therapy-fact-sheet. Last accessed July 10, 2018.

113. American Cancer Society. Breast Reconstruction Surgery. Available at https://www.cancer.org/cancer/breast-cancer/reconstruction-surgery.html. Last accessed July 10, 2018.

114. National Cancer Institute. Surgery to Reduce the Risk of Breast Cancer. Available at https://www.cancer.gov/types/breast/risk-reducing-surgery-fact-sheet. Last accessed July 10, 2018.

115. American Cancer Society. Breast Reconstruction Using Your Own Tissues (Flap Procedures). Available at https://www.cancer.org/cancer/breast-cancer/reconstruction-surgery/breast-reconstruction-options/breast-reconstruction-using-your-own-tissues-flap-procedures.html. Last accessed July 5, 2018.

116. Wagner LH, Ruth-Sahd LA. Pregnancy after a TRAM flap procedure: principles of nursing care. J Obstet Gynecol Neonatal Nurs. 2000;29(4):363-368.

117. Mayo Clinic. Breast Reconstruction with Flap Surgery. Available at https://www.mayoclinic.org/tests-procedures/breast-reconstruction-flap/about/pac-20384937. Last accessed July 10, 2018.

118. American Cancer Society. Breast Reconstruction Using Implants. Available at https://www.cancer.org/cancer/breast-cancer/reconstruction-surgery/breast-reconstruction-options/breast-reconstruction-using-implants.html. Last accessed July 5, 2018.

119. American Cancer Society. Should I Get Breast Reconstruction Surgery? Available at https://www.cancer.org/cancer/breast-cancer/reconstruction-surgery/should-i-get-breast-reconstruction-surgery.html. Last accessed July 5, 2018.

120. Breastcancer.org. TRAM Flap Reconstruction: What to Expect. Available at https://www.breastcancer.org/treatment/surgery/reconstruction/types/autologous/tram/what-to-expect. Last accessed July 10, 2018.

121. American Cancer Society. What to Expect After Breast Reconstruction Surgery. Available at https://www.cancer.org/cancer/breast-cancer/reconstruction-surgery/what-to-expect-after-breast-reconstruction-surgery.html. Last accessed July 5, 2018.

122. Early Breast Cancer Trialists' Collaborative Group (EBCTCG). Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005;365(9472):1687-1717.

123. National Cancer Institute. Extended Adjuvant Therapy Beneficial for Some women with Breast Cancer. Available at https://www.cancer.gov/news-events/cancer-currents-blog/2016/adjuvant-aromatase-breast. Last accessed July 10, 2018.

124. Forbes JF, Cuzick J, Buzdar A, Howell A, Tobias JS, Baum M. Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 100-month analysis of the ATAC trial. Lancet Oncol. 2008;9(1):45-53.

125. Joy AA. San Antonio Breast Cancer Symposium 2007—adjuvant endocrine therapy update: ATAC 100 highlights. Curr Oncol. 2008;15(1):68-69.

126. Zhou J, Wu SG, Wang JJ, et al. Ovarian ablation using goserelin improves survival of premenopausal patients with stage II/III hormone receptor-positive breast cancer without chemotherapy-induced amenorrhea. Cancer Res Treat. 2015;47(1):55-63.

127. Zhang P, Li CZ, Jiao GM, et al. Effects of ovarian ablation or suppression in premenopausal breast cancer: a meta-analysis of randomized controlled trials. Eur J Surg Oncol. 2017;43(7):1161-1172.

128. Roux G, Dingley CE, Bush HB. Inner strength in women: metasynthesis of qualitative findings in theory development. J Theory Construction Testing. 2002;6(1):86-93.

129. Murphy SL, Xu J, Kochanek KD, Curtin SC, Arias E. Deaths: final data for 2015. Natl Vital Stat Rep. 2017;66(6):1-73.

130. Maxson J. Remedying dyslipidemia NCEP-ATP III strategies to slow CVD. Clin Rev. 2002;12(10):53-60.

131. Womenshealth.gov. Heart Disease and Women Fact Sheet. Available at https://www.womenshealth.gov/files/documents/fact-sheet-heart-disease-and-women.pdf. Last accessed July 10, 2018.

132. American Heart Association. Facts: Cardiovascular Disease: Women's No. 1 Health Threat. Available at http://www.heart.org/idc/groups/heart-public/@wcm/@adv/documents/downloadable/ucm_302256.pdf. Last accessed July 10, 2018.

133. Penque S, Halm M, Smith M, et al. Women and coronary disease: relationship between descriptors of signs and symptoms and diagnostic and treatment course. Am J Crit Care. 1998;7(3):175-182.

134. Clouse AL, Sherif K. Women's Health in Clinical Practice: A Handbook for Primary Care. Totowa, NJ: Humana Press; 2008.

135. Bairey Merz CN, Shaw LJ, Reis SE, et al. Insights From the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE) Study. Part II: gender differences in presentation, diagnosis, and outcome with regard to gender-based pathophysiology of atherosclerosis and macrovascular and microvascular coronary disease. J Am Coll Cardiol. 2006;47(3 suppl):S21-S29.

136. Pepine CJ, Kerensky RA, Lambert CR, et al. Some thoughts on the vasculopathy of women with ischemic heart disease. J Am Coll Cardiol. 2006;47(3 suppl):S30-S35.

137. National Heart, Lung, and Blood Institute. What Are the Risk Factors for Heart Disease? Available at https://www.nhlbi.nih.gov/health/educational/hearttruth/lower-risk/risk-factors.htm. Last accessed July 6, 2018.

138. Fryar CD, Carroll MD, Ogden CL. Prevalence of Overweight, Obesity, and Extreme Obesity Among Adults: United States, Trends 1960–1962 through 2011–2012. Available at https://www.cdc.gov/nchs/data/hestat/obesity_adult_11_12/obesity_adult_11_12.htm. Last accessed July 10, 2018.

139. Womenshealth.gov. Top Questions About Fitness and Women Fact Sheet. Available at https://www.womenshealth.gov/files/documents/fact-sheet-fitness-and-women.pdf. Last accessed July 10, 2018.

140. Kealy MM. Preventing obesity. Nurs Womens Health. 2003;7(1):24-27.

141. Tipton KD, Wolfe RR. Exercise, protein metabolism, and muscle growth. Int J Sport Nutr Exerc Metab. 2001;11(1):109-132.

142. Souhami RL, Moxham J. Textbook of Medicine. 4th ed. Philadelphia, PA: Elsevier Health Sciences; 2002.

143. Oliver JE. Fat Politics: The Real Story Behind America's Obesity Epidemic. New York, NY: Oxford University Press; 2006.

144. Mehta T, Smith DL Jr, Muhammad J, Casazza K. Impact of weight cycling on risk of morbidity and mortality. Obes Rev. 2014;15(11):870-881.

145. U.S. Department of Health and Human Services. 2008 Physical Activity Guidelines for Americans. Available at https://health.gov/paguidelines/pdf/paguide.pdf. Last accessed July 10, 2018.

146. Thompson PD, Buchner D, Piña IL, et al. Exercise and physical activity in the prevention and treatment of atherosclerotic cardiovascular disease: a statement from the Council on Clinical Cardiology (Subcommittee on Exercise, Rehabilitation, and Prevention) and the Council on Nutrition, Physical Activity, and Metabolism (Subcommittee on Physical Activity). Circulation. 2003;107(24):3109-3116.

147. U.S. Department of Agriculture. ChooseMyPlate. Available at https://www.choosemyplate.gov. Last accessed July 10, 2018.

148. National Institutes of Health Office of Dietary Supplements. Calcium: Fact Sheet for Health Professionals. Available at https://ods.od.nih.gov/factsheets/Calcium-HealthProfessional. Last accessed July 10, 2018.

149. Dudek SG. Nutrition Handbook for Nursing Practice. 6th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2010.

150. Womenshealth.gov. Iron-Deficiency Anemia Fact Sheet. Available at https://www.womenshealth.gov/a-z-topics/iron-deficiency-anemia?from=AtoZ. Last accessed July 10, 2018.

151. International Food Information Council Foundation. The Truth about Fats and Oils and Health. Available at https://www.foodinsight.org/The_Truth_about_Fats_and_Oils_and_Health. Last accessed July 10, 2018.

152. American Heart Association. The American Heart Association's Diet and Lifestyle Recommendations. Available at http://www.heart.org/HEARTORG/HealthyLiving/HealthyEating/Nutrition/The-American-Heart-Associations-Diet-and-Lifestyle-Recommendations_UCM_305855_Article.jsp#.WywPjOS0WIV. Last accessed July 10, 2018.

153. Erickson JD. Folic acid and prevention of spinal bifida and anencephaly: 10 years after the U.S. Public Health Service recommendation. MMWR. 2002;51(RR13):1-3.

154. U.S. Department of Health and Human Services, U.S. Department of Agriculture. Dietary Guidelines for Americans, 2015–2020. Available at https://health.gov/dietaryguidelines/2015/resources/2015-2020_Dietary_Guidelines.pdf. Last accessed July 10, 2018.

155. The Cleveland Clinic. Diabetes Mellitus: An Overview. Available at https://my.clevelandclinic.org/health/diseases/7104-diabetes-mellitus-an-overview. Last accessed July 10, 2018.

156. Centers for Disease Control and Prevention. Diabetes Data and Statistics. Available at https://www.cdc.gov/diabetes/data. Last accessed July 10, 2018.

157. American Diabetes Association. Standards of medical care in diabetes—2018. J Clin App Res Ed. 2018;41(Suppl 1):S1-S159.

158. National Osteoporosis Foundation. What is Osteoporosis? Available at https://www.nof.org/patients/what-is-osteoporosis. Last accessed July 10, 2018.

159. Womenshealth.gov. Osteoporosis Fact Sheet. Available at https://www.womenshealth.gov/a-z-topics/osteoporosis?from=AtoZ. Last accessed July 10, 2018.

160. MedlinePlus. Menopause. Available at https://medlineplus.gov/menopause.html. Last accessed July 10, 2018.

161. Office of the Surgeon General. Report of the Surgeon General's Workshop on Osteoporosis and Bone Health: December 12–13, 2002. Washington, DC. Rockville, MD: Office of the Surgeon General; 2003.

162. National Osteoporosis Foundation. Preventing Fractures: Prevention. Available at https://www.nof.org/preventing-fractures/prevention/. Last accessed July 7, 2018.

163. Research America. Osteoporosis and Hip Fractures. Available at https://cdn.nof.org/wp-content/uploads/2017/02/OsteoporosisHip-Fracture_2017.pdf. Last accessed July 7, 2018.

164. National Institute of Arthritis and Musculoskeletal and Skin Diseases. Osteoporosis. Available at https://www.bones.nih.gov/health-info/bone/osteoporosis. Last accessed July 10, 2018.

165. National Institutes of Health. Calcium and Vitamin D: Important at Every Age. Available at https://www.bones.nih.gov/health-info/bone/bone-health/nutrition/calcium-and-vitamin-d-important-every-age. Last accessed July 10, 2018.

166. Ekwaru JP, Zwicker JD, Holick MF, Giovannucci E, Veugelers PJ. The importance of body weight for the dose response relationship of oral vitamin D supplementation and serum 25-hydroxyvitamin D in healthy volunteers. PLoS One. 2014;9(11):e111265.

167. Bjelakovic G, Gluud LL, Nikolova D, et al. Vitamin D supplementation for prevention of mortality in adults. Cochrane Database Syst Rev. 2011;(7):CD007470.

168. Bjelakovic G, Gluud LL, Nikolova D, et al. Vitamin D supplementation for prevention of mortality in adults. Cochrane Database Syst Rev. 2014;1:CD007470.

169. Terushkin V, Bender A, Psaty EL, Engelsen O, Wang SQ, Halpern AC. Estimated equivalency of vitamin D production from natural sun exposure versus oral vitamin D supplementation across seasons at two U.S. latitudes. J Am Acad Dermatol. 2010;62(6):929.e1-e9.

170. Adami S, Idolazzi L, Rossini M. Evidence of sustained vertebral and nonvertebral antifracture efficacy with ibandronate therapy: a systematic review. Ther Adv Musculoskelet Dis. 2011;3(2):67-79.

171. World Health Organization. Mental Health: A State of Well Being. Available at http://www.who.int/features/factfiles/mental_health/en. Last accessed July 10, 2018.

172. U.S. Preventive Services Task Force. Depression in Adults: Screening. Available at https://www.uspreventiveservicestaskforce.org/Page/Document/UpdateSummaryFinal/depression-in-adults-screening1. Last accessed July 7, 2018.

173. National Institute of Mental Health. Depression. Available at https://www.nimh.nih.gov/health/topics/depression/index.shtml. Last accessed July 10, 2018.

174. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed. Arlington, VA: American Psychiatric Association; 2013.

175. Zung WW. The role of rating scales in the identification and management of the depressed patient in the primary care setting.J Clin Psychiatry. 1990;(51 suppl):72-76.

176. National Center for Injury Prevention and Control. WISQARS Leading Causes of Death Reports, National and Regional, 1999–2015. Available at http://webappa.cdc.gov/sasweb/ncipc/leadcaus10_us.html. Last accessed July 10, 2018.

177. National Institute of Mental Health. Suicide Prevention. Available at https://www.nimh.nih.gov/health/topics/suicide-prevention/index.shtml. Last accessed July 10, 2018.

178. Anxiety and Depression Association of America. Facts and Statistics. Available at https://adaa.org/about-adaa/press-room/facts-statistics. Last accessed July 7, 2018.

179. National Institute of Mental Health. Anxiety Disorders. Available at https://www.nimh.nih.gov/health/topics/anxiety-disorders/index.shtml. Last accessed July 10, 2018.

180. Uphold CR, Graham MV. Clinical Guidelines in Family Practice. 4th ed. Gainesville, FL: Barmarrae Books; 2003.

181. American Psychiatric Association. Intimate Partner Abuse and Relationship Violence. Available at http://www.apa.org/about/division/activities/partner-abuse.pdf. Last accessed July 10, 2018.

182. U.S. Preventive Services Task Force. Intimate Partner Violence and Abuse of Elderly and Vulnerable Adults: Screening. Available at https://www.uspreventiveservicestaskforce.org/Page/Document/RecommendationStatementFinal/intimate-partner-violence-and-abuse-of-elderly-and-vulnerable-adults-screening. Last accessed July 10, 2018.

183. Sprague S, Madden K, Dosanjh S, Petrisor B, Schemitsch EH, Bhandari M. Screening for intimate partner violence in orthopedic patients: a comparison of three screening tools. J Interpers Violence. 2012;27(5):881-898.

184. National Center for Injury Prevention and Control. WISQARS Fatal Injury Reports, National and Regional, 1999–2015. Available at http://webappa.cdc.gov/sasweb/ncipc/mortrate10_us.html. Last accessed July 10, 2018.

185. Centers for Disease Control and Prevention. Patterns of Unintentional Injuries among 0-19 Year Olds in the United States, 2000–2006. Available at https://www.cdc.gov/safechild/images/CDC-ChildhoodInjury.pdf. Last accessed July 10, 2018.

186. National Rifle Association. Safety Programs: Eddie Eagle. Available at https://eddieeagle.nra.org. Last accessed July 10, 2018.

187. Substance Abuse and Mental Health Services Administration. Study: More Than 1 in 10 Children Live with a Substance Abusing Parent. Available at https://www.samhsa.gov/newsroom/press-announcements/200904290100. Last accessed July 10, 2018.

188. National Institute on Drug Abuse. Health Consequences of Drug Misuse. Available at https://www.drugabuse.gov/publications/health-consequences-drug-misuse/death. Last accessed July 7, 2018.

189. D'Amico EJ, Paddock SM, Burnam A, Kung FY. Identification of and guidance for problem drinking by general medical providers: results from a national survey. Med Care. 2005;43(3):229-236.

190. Becker KL, Walton-Moss B. Detecting and addressing alcohol abuse in women. Nurse Pract. 2001;26(10):13-16, 19-23.

191. Ewing, JA. Detecting alcoholism: the CAGE questionnaire. JAMA. 1984;252(14):1905-1907.

192. Knight JR, Sherritt L, Shrier LA, Harris SK, Chang G. Validity of CRAFFT substance abuse screening test among adolescent clinic patients. Arch Pediatr Adolesc Med. 2002;156(6):607-614.

193. Dhalla S, Zumbo BD, Poole G. A review of the psychometric properties of the CRAFFT instrument: 1999–2010. Curr Drug Abuse Rev. 2011;4(1):57-64.

194. Running A, Berndt A. Management Guidelines for Nurse Practitioners Working in Family Practice. Philadelphia, PA: F.A. Davis Company; 2003.

195. Martin AC, Schaeffer SD, Campbell R. Managing alcohol-related problems in the primary care setting. Nurse Pract. 1999;24(8): 14-39.

196. National Institute on Drug Abuse. NIDA InfoFacts: Lessons from Prevention Research. Available at https://www.drugabuse.gov/publications/drugfacts/lessons-prevention-research. Last accessed July 10, 2018.

197. Office on Women's Health. A-Z Health Topics. Available at https://www.womenshealth.gov/a-z-topics. Last accessed July 7, 2018.

198. The Office of Research on Women's Health: National Institutes of Health. Women of Color: Health Data Book. Available at https://orwh.od.nih.gov/sites/orwh/files/docs/WoC-Databook-FINAL.pdf. Last accessed July 9, 2018.

199. Pippitt K, Li M, Gurgle HE. Diabetes mellitus: screening and diagnosis. Am Fam Physician. 2016;93(2):103-109.

200. American Heart Association. Heart-Health Screenings. Available at http://www.heart.org/HEARTORG/Conditions/Heart-Health-Screenings_UCM_428687_Article.jsp#.W0OUWuS0WIU. Last accessed July 9, 2018.

201. Spanakis EK, Golden SH. Race/ethnic difference in diabetes and diabetic complications. Curr Diab Rep. 2013;13(6):10.

202. Centers for Disease Control and Prevention. HIV Among Women. Available at https://www.cdc.gov/hiv/group/gender/women/index.html. Last accessed July 9, 2018.

203. HIV/AIDS and Hispanic/Latino Youth. Available at https://www.latinoaids.org/docs/latino_youth_hiv.pdf. Last accessed July 9, 2018.

204. Ou Y. Glaucoma in the African American and Hispanic Communities. Available at https://www.brightfocus.org/glaucoma/article/glaucoma-african-american-and-hispanic-communities. Last accessed July 9, 2018.

205. Glaucoma Research Foundation. Hispanic Americans and Latinos at Increased Glaucoma Risk. Available at https://www.glaucoma.org/gleams/hispanic-americans-at-increased-risk-for-glaucoma.php. Last accessed July 9, 2018.

206. Office of Minority Health. Diabetes and African Americans. Available at https://minorityhealth.hhs.gov/omh/browse.aspx?lvl=4&lvlid=18. Last accessed July 9, 2018.

207. Centers for Disease Control and Prevention. Deaths, Percent of Total Deaths, and Death Rates for the 15 Leading Causes of Death in 5-Year Age Groups, by Race and Sex: United States, 1999–2013. Available at https://www.cdc.gov/nchs/data/dvs/LCWK1_2013.pdf. Last accessed July 10, 2018.

208. Centers for Disease Control and Prevention. Deaths, Percent of Total Deaths, and Death Rates for the 15 Leading Causes of Death in 5-Year Age Groups, by Hispanic Origin, Race for Non-Hispanic Population and Sex: United States, 1999–2013. Available at https://www.cdc.gov/nchs/data/dvs/LCWK4_2013.pdf. Last accessed July 10, 2018.

209. Centers for Disease Control and Prevention. Leading Causes of Death in Females, 2015. Available at https://www.cdc.gov/women/lcod/2015/race-ethnicity/index.htm. Last accessed July 9, 2018.

210. Dossey BM, Keegan L. Holistic Nursing: A Handbook for Practice. 5th ed. Sudbury, MA: Jones and Bartlett Publishers; 2009.

211. Holisticonline. Alternative Medicine: Definitions. Available at http://holisticonline.com/Alt_Medicine/altmed_definitions.htm. Last accessed July 10, 2018.

212. National Center for Complementary and Integrative Health. Available at https://nccih.nih.gov. Last accessed July 10, 2018.

213. MedlinePlus. Dong Quai. Available at https://medlineplus.gov/druginfo/natural/936.html. Last accessed July 10, 2018.

214. MedlinePlus. Evening Primrose Oil. Available at https://nccih.nih.gov/health/eveningprimrose. Last accessed July 10, 2018.

215. American Holistic Nurses Association. Available at http://www.ahna.org. Last accessed July 10, 2018.

216. Buckle J. Clinical aromatherapy: therapeutic uses for essential oils. Adv Nurse Pract. 2002;10(5):67-68, 88.

217. MedlinePlus. Lavender. Available at https://nccih.nih.gov/health/lavender/ataglance.htm. Last accessed July 10, 2018.

218. Goldberg B, Goldberg MA. Alternative Medicine: The Definitive Guide. 2nd ed. Berkeley, CA: Ten Speed Press; 2002.

219. Holisticonline. Guided Imagery or Visualization. Available at http://www.holisticonline.com/guided-imagery.htm. Last accessed July 10, 2018.

220. Simonton OC, Creighton J, Matthews S. Getting Well Again. Reissue. New York, NY: Bantam Books; 1992.

221. Harsora P, Kessman J. Nonpharmacologic management of chronic insomnia. Am Fam Physician. 2009;79(2):125-130.

222. Merck Manual. Mind-Body Techniques. Available at https://www.merckmanuals.com/home/special-subjects/complementary-and-alternative-medicine-cam/mind-body-techniques. Last accessed July 10, 2018.

223. Holisticonline. Health Conditions that are Benefited by Meditation. Available at http://1stholistic.com/Meditation/hol_meditation_benefits_health_conditions.htm. Last accessed July 10, 2018.

224. Holisticonline. Yoga. Available at http://holisticonline.com/Yoga/hol_yoga_home.htm. Last accessed July 10, 2018.

225. Begley SS. The energetic language of therapeutic touch: a holistic tool for nurse practitioners. Adv Nurse Pract. 2002;10(5):69-71.

226. Mish FC, Copeland RD, Despres JM, Lowe JG, Pease RW Jr. Rader JL (eds). The Merriam-Webster Dictionary. 11th ed. Springfield, MA: Merriam Webster Mass Market; 2004.

227. American Speech-Language-Hearing Association. Hearing Screening. Available at https://www.asha.org/public/hearing/Hearing-Screening. Last accessed July 9, 2018.

228. Womenshealth.gov. Steps for Better Health by Age. Available at https://www.womenshealth.gov/nwhw/by-age. Last accessed July 10, 2018.

229. U.S. Preventive Services Task Force. Thyroid Dysfunction: Screening. Available at https://www.uspreventiveservicestaskforce.org/Page/Document/UpdateSummaryFinal/thyroid-dysfunction-screening. Last accessed July 10, 2018.

230. U.S. Preventive Services Task Force. Screening for Colorectal Cancer. Available at https://www.uspreventiveservicestaskforce.org/Page/Document/UpdateSummaryFinal/colorectal-cancer-screening2. Last accessed July 9, 2018.

231. American Dental Association. American Dental Association Statement on Regular Dental Visits. Available at https://www.ada.org/en/press-room/news-releases/2013-archive/june/american-dental-association-statement-on-regular-dental-visits. Last accessed July 10, 2018.

232. American Optometric Association. Recommended Eye Examination Frequency for Pediatric Patients and Adults. Available at https://www.aoa.org/patients-and-public/caring-for-your-vision/comprehensive-eye-and-vision-examination/recommended-examination-frequency-for-pediatric-patients-and-adults?sso=y. Last accessed July 10, 2018.

233. Centers for Disease Control and Prevention. ACIP Vaccine Recommendations and Guidelines. Available at https://www.cdc.gov/vaccines/hcp/acip-recs/index.html. Last accessed July 10, 2018.

234. Centers for Disease Control and Prevention. Recommended Immunization Schedule for Adults Aged 19 Years or Older, United States 2018. Available at https://www.cdc.gov/vaccines/schedules/hcp/adult.html. Last accessed July 10, 2018.

235. Grohskopf L, Sikolow LZ, Fry AM, Walter EB, Jernigan DB. Update: ACIP recommendations for the use of quadrivalent live attenuated influenza vaccine (LAIV4)—United States, 2018–19 influenza season. MMWR. 2018;67(22):643-645.

236. U.S. Food and Drug Administration. FDA Approves Expanded Use of Gardasil 9 to Include Individuals 27 through 45 Years Old. Available at https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm622715.htm. Last accessed October 11, 2018.

237. U.S. Food and Drug Administration. FDA Approves New Treatment for Osteoporosis in Postmenopausal Women at High Risk of Fracture. Available at https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm635653.htm. Last accessed April 22, 2019.

Evidence-Based Practice Recommendations Citations

1. Meites E, Kempe A, Markowitz LE. Use of a 2-dose schedule for human papillomavirus vaccination—updated recommendations of the Advisory Committee on Immunization Practices. MMWR. 2016;65(49):1405-1408. Available at https://www.cdc.gov/mmwr/volumes/65/wr/mm6549a5.htm. Last accessed July 19, 2018.

2. Centers for Disease Control and Prevention. Chlamydial infections. In: Sexually transmitted diseases treatment guidelines, 2015.MMWR. 2015;64(3):55-59. Available at https://www.cdc.gov/std/tg2015. Last accessed July 19, 2018.

3. Faculty of Sexual and Reproductive Healthcare. Contraception for Women Aged Over 40 Years. London: Faculty of Sexual and Reproductive Healthcare; 2017. Available at https://www.fsrh.org/standards-and-guidance/documents/fsrh-guidance-contraception-for-women-aged-over-40-years-2017/fsrh-guideline-contraception-for-women-aged-over-40-years.pdf. Last accessed July 19, 2018.

4. The North American Menopause Society. The 2017 hormone therapy position statement of The North American Menopause Society. Menopause. 2017;24(7):728-753. Available at https://www.menopause.org/docs/default-source/2017/nams-2017-hormone-therapy-position-statement.pdf. Last accessed July 19, 2018.

5. U.S. Preventive Services Task Force. BRCA-Related Cancer: Risk Assessment, Genetic Counseling, and Genetic Testing. Available at https://www.uspreventiveservicestaskforce.org/Page/Document/UpdateSummaryFinal/brca-related-cancer-risk-assessment-genetic-counseling-and-genetic-testing. Last accessed July 19, 2018.

6. McSweeney JC, Rosenfeld AG, Abel WM, et al. Preventing and experiencing ischemic heart disease as a woman: state of the science: a scientific statement from the American Heart Association. Circulation. 2016;133(13):1302-1331. Available at http://circ.ahajournals.org/content/133/13/1302. Last accessed July 19, 2018.

7. Allen S, Forney-Gorman A, Homan M, Kearns A, Kramlinger A, Sauer M. Diagnosis and Treatment of Osteoporosis. Bloomington, MN: Institute for Clinical Systems Improvement; 2017. Available at https://www.icsi.org/_asset/vnw0c3/Osteo.pdf. Last accessed July 19, 2018.


Copyright © 2018 NetCE, P.O. Box 997571, Sacramento, CA 95899-7571
Mention of commercial products does not indicate endorsement.